PUTRAJAYA: Swiss healthcare giant Roche Pharmaceuticals has picked Malaysia's Sarawak General Hospital as its global First-in-Human (FIH) clinical trial site.
Malaysia will be the seventh country included by Roche for the study and the first within the Asia Pacific region.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
